CD44 and breast cancer: The tumourigenic properties of breast cancer have been attributed to a population of CD44+CD24-/low cells (accounting for 11–35% of the bulk tumour), isolated from primary tumour tissue, that give rise to malignancies in xenograft models, following orthotopic transplantation into the mammary fat pad of NOD/SCID mice [13].